LOCALLY ADVANCED UNRESECTABLE CHOLANGIOCARCINOMA

Clinical trials for LOCALLY ADVANCED UNRESECTABLE CHOLANGIOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new LOCALLY ADVANCED UNRESECTABLE CHOLANGIOCARCINOMA trials appear

Sign up with your email to follow new studies for LOCALLY ADVANCED UNRESECTABLE CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Scientists test Triple-Threat attack on Tough-to-Treat cancers

Disease control Ongoing

This study is testing a new three-part treatment for people with advanced cancers that have spread. It combines a new pill (peposertib), an immunotherapy drug (avelumab), and a short, high-dose course of radiation. The goal is to see if this combination can better control cancer …

Matched conditions: LOCALLY ADVANCED UNRESECTABLE CHOLANGIOCARCINOMA

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

LOCALLY ADVANCED UNRESECTABLE CHOLANGIOCARCINOMA

Get alerted when new LOCALLY ADVANCED UNRESECTABLE CHOLANGIOCARCINOMA trials appear

Scientists test Triple-Threat attack on Tough-to-Treat cancers